Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 17, 2009

Takara Bio Negotiates License to Roche Diagnostics’ Melting Curve Analysis and SYBR Green Techniques

  • Takara Bio has obtained a nonexclusive license from Roche Diagnostics for use of melting curve analysis technology and SYBR Green techniques in its kits and instruments for real-time PCR. The license specifically covers reagent and/or methods for instrument use in Japan and worldwide use in kits.

    Melting curve analysis is a technique for analysis of PCR products. After PCR, the resulting PCR product is slowly heated. Each double-stranded DNA has its own specific melting temperature (Tm), which is defined as the temperature at which 50% of the DNA becomes single stranded. By measurement of Tm, the DNA can be easily identified.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »